Robex Lodges Prospectus for IPO to Raise A$120M Ahead of ASX Listing
Not for release to US wire services or distribution in the United States Highlights: Robex Resources has lodged a prospectus...
Read moreDetails
Eros Resources Announces Approval of Name Change and Share Consolidation
Vancouver, BC, April 17, 2025 (GLOBE NEWSWIRE) -- Eros Resources Corp. (TSXV: ROCK) (OTCQB: EROSF) (“Eros” or the “Company”) announces the...
Read moreDetailsOMNI-LITE INDUSTRIES ANNOUNCES DATE OF FOURTH QUARTER AND FISCAL 2024 RESULTS
LOS ANGELES, CALIFORNIA, April 17, 2025 (GLOBE NEWSWIRE) -- Omni-Lite Industries Canada Inc. (the "Company" or “Omni-Lite”; TSXV: OML) today...
Read moreDetailsPerspective Therapeutics to Provide Business Highlights and Report First Quarter 2025 Financial Results
SEATTLE, April 17, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering...
Read moreDetailsSpecial Needs Network Honors Artist Shanice with Lifetime Achievement Award
Welcomes Tess Mann Atelier as Fashion Show Presenter for 17th Annual A Pink Pump Affair 2025 Pink Pump Affair 2025...
Read moreDetailsORIGENCE ANNOUNCES SHERYL CONNELLY AS KEYNOTE SPEAKER FOR LENDING TECH LIVE ’25 CONFERENCE
Sheryl Connelly, keynote speaker Lending Tech Live '25 welcomes former Chief Futurist at Ford Motor Company, Sheryl Connelly, as keynote...
Read moreDetailsRing Energy Provides Operational Update
~ Announces Timing of First Quarter Earnings Conference Call ~ THE WOODLANDS, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Ring...
Read moreDetailsChagee Holdings Limited Announces Pricing of Initial Public Offering
SHANGHAI, April 17, 2025 (GLOBE NEWSWIRE) -- Chagee Holdings Limited (“Chagee” or the “Company”), a leading premium tea drinks brand...
Read moreDetailsAventon Announces the All-New Pace 4 with Smart Bike technology
Next-generation electric bike with 4G/GPS and Theft Deterrent features enabled by the ACU(Aventon Control Unit), empowering more control for the...
Read moreDetailsLigand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos’...
Read moreDetailsADVERTISEMENTS
